NLRC4 and macrophage activation syndrome: The most severe clinical phenotype (NLRC4-MAS) is dominated by a multisystemic inflammation starting in the first year of life with symptoms of chronic inflammatory bowel disease, MAS, or symptoms resembling CINCA/NOMID.